Global Generic Injectables Market Research Report 2019

Table of Contents

Executive Summary

1 Generic Injectables Market Overview

• 1.1 Product Overview and Scope of Generic Injectables
• 1.2 Generic Injectables Segment by Type
  • 1.2.1 Global Generic Injectables Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Large Molecule Injectables (Biosimilars)
  • 1.2.3 Small Molecule Injectables
• 1.3 Generic Injectables Segment by Application
  • 1.3.1 Generic Injectables Consumption Comparison by Application (2014-2025)
  • 1.3.2 Oncology
  • 1.3.3 Infectious Diseases
  • 1.3.4 Cardiology
  • 1.3.5 Diabetes
  • 1.3.6 Immunology
• 1.4 Global Generic Injectables Market by Region
  • 1.4.1 Global Generic Injectables Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Generic Injectables Market Size
  • 1.5.1 Global Generic Injectables Revenue (2014-2025)
  • 1.5.2 Global Generic Injectables Production (2014-2025)

2 Global Generic Injectables Market Competition by Manufacturers

• 2.1 Global Generic Injectables Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Generic Injectables Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Generic Injectables Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Generic Injectables Production Sites, Area Served, Product Types
• 2.5 Generic Injectables Market Competitive Situation and Trends
  • 2.5.1 Generic Injectables Market Concentration Rate
  • 2.5.2 Generic Injectables Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Generic Injectables Production Market Share by Regions

• 3.1 Global Generic Injectables Production Market Share by Regions
• 3.2 Global Generic Injectables Revenue Market Share by Regions (2014-2019)
• 3.3 Global Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Generic Injectables Production
  • 3.4.1 North America Generic Injectables Production Growth Rate (2014-2019)
  • 3.4.2 North America Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Generic Injectables Production
  • 3.5.1 Europe Generic Injectables Production Growth Rate (2014-2019)
  • 3.5.2 Europe Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Generic Injectables Production (2014-2019)
  • 3.6.1 China Generic Injectables Production Growth Rate (2014-2019)
  • 3.6.2 China Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Generic Injectables Production (2014-2019)
  • 3.7.1 Japan Generic Injectables Production Growth Rate (2014-2019)
  • 3.7.2 Japan Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Generic Injectables Consumption by Regions

• 4.1 Global Generic Injectables Consumption by Regions
• 4.2 North America Generic Injectables Consumption (2014-2019)
• 4.3 Europe Generic Injectables Consumption (2014-2019)
• 4.4 China Generic Injectables Consumption (2014-2019)
• 4.5 Japan Generic Injectables Consumption (2014-2019)

5 Global Generic Injectables Production, Revenue, Price Trend by Type

• 5.1 Global Generic Injectables Production Market Share by Type (2014-2019)
• 5.2 Global Generic Injectables Revenue Market Share by Type (2014-2019)
• 5.3 Global Generic Injectables Price by Type (2014-2019)
• 5.4 Global Generic Injectables Production Growth by Type (2014-2019)

6 Global Generic Injectables Market Analysis by Applications

• 6.1 Global Generic Injectables Consumption Market Share by Application (2014-2019)
• 6.2 Global Generic Injectables Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Generic Injectables Business

• 7.1 Pfizer
  • 7.1.1 Pfizer Generic Injectables Production Sites and Area Served
  • 7.1.2 Generic Injectables Product Introduction, Application and Specification
  • 7.1.3 Pfizer Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Sandoz International
  • 7.2.1 Sandoz International Generic Injectables Production Sites and Area Served
  • 7.2.2 Generic Injectables Product Introduction, Application and Specification
  • 7.2.3 Sandoz International Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Baxter
  • 7.3.1 Baxter Generic Injectables Production Sites and Area Served
  • 7.3.2 Generic Injectables Product Introduction, Application and Specification
  • 7.3.3 Baxter Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Fresenius
  • 7.4.1 Fresenius Generic Injectables Production Sites and Area Served
  • 7.4.2 Generic Injectables Product Introduction, Application and Specification
  • 7.4.3 Fresenius Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Mylan
  • 7.5.1 Mylan Generic Injectables Production Sites and Area Served
  • 7.5.2 Generic Injectables Product Introduction, Application and Specification
  • 7.5.3 Mylan Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Teva Pharmaceutical
  • 7.6.1 Teva Pharmaceutical Generic Injectables Production Sites and Area Served
  • 7.6.2 Generic Injectables Product Introduction, Application and Specification
  • 7.6.3 Teva Pharmaceutical Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Hikma Pharmaceuticals
  • 7.7.1 Hikma Pharmaceuticals Generic Injectables Production Sites and Area Served
  • 7.7.2 Generic Injectables Product Introduction, Application and Specification
  • 7.7.3 Hikma Pharmaceuticals Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Lupin Pharmaceuticals
  • 7.8.1 Lupin Pharmaceuticals Generic Injectables Production Sites and Area Served
  • 7.8.2 Generic Injectables Product Introduction, Application and Specification
  • 7.8.3 Lupin Pharmaceuticals Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Sanofi
  • 7.9.1 Sanofi Generic Injectables Production Sites and Area Served
  • 7.9.2 Generic Injectables Product Introduction, Application and Specification
  • 7.9.3 Sanofi Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Biocon
  • 7.10.1 Biocon Generic Injectables Production Sites and Area Served
  • 7.10.2 Generic Injectables Product Introduction, Application and Specification
  • 7.10.3 Biocon Generic Injectables Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served

8 Generic Injectables Manufacturing Cost Analysis

• 8.1 Generic Injectables Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Generic Injectables
• 8.4 Generic Injectables Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Generic Injectables Distributors List
• 9.3 Generic Injectables Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Generic Injectables Market Forecast

• 11.1 Global Generic Injectables Production, Revenue Forecast
  • 11.1.1 Global Generic Injectables Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Generic Injectables Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Generic Injectables Price and Trend Forecast (2019-2025)
• 11.2 Global Generic Injectables Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Generic Injectables Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Generic Injectables Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Generic Injectables Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Generic Injectables Production, Revenue Forecast (2019-2025)
• 11.3 Global Generic Injectables Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Generic Injectables Consumption Forecast (2019-2025)
  • 11.3.2 Europe Generic Injectables Consumption Forecast (2019-2025)
  • 11.3.3 China Generic Injectables Consumption Forecast (2019-2025)
  • 11.3.4 Japan Generic Injectables Consumption Forecast (2019-2025)
• 11.4 Global Generic Injectables Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Generic Injectables Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List